163 related articles for article (PubMed ID: 12682008)
1. A redox-sensitive loop regulates plasminogen activator inhibitor type 2 (PAI-2) polymerization.
Wilczynska M; Lobov S; Ohlsson PI; Ny T
EMBO J; 2003 Apr; 22(8):1753-61. PubMed ID: 12682008
[TBL] [Abstract][Full Text] [Related]
2. Structural bases of the redox-dependent conformational switch in the serpin PAI-2.
Lobov S; Wilczynska M; Bergström F; Johansson LB; Ny T
J Mol Biol; 2004 Dec; 344(5):1359-68. PubMed ID: 15561148
[TBL] [Abstract][Full Text] [Related]
3. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 is locked in active conformation and polymerizes upon binding ligands neutralizing its activity.
Jankun J; Specht Z; Szkudlarek M; Greenfield R; Gaikwad B; Trifonov L; Vaugeois J; Aleem AM; Basrur V; Selman SH; Zavodszky MI; Skrzypczak-Jankun E
Int J Mol Med; 2006 Mar; 17(3):437-47. PubMed ID: 16465390
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.
Pedersen KE; Einholm AP; Christensen A; Schack L; Wind T; Kenney JM; Andreasen PA
Biochem J; 2003 Jun; 372(Pt 3):747-55. PubMed ID: 12656676
[TBL] [Abstract][Full Text] [Related]
6. Intracellular polymerization of the serpin plasminogen activator inhibitor type 2.
Mikus P; Ny T
J Biol Chem; 1996 Apr; 271(17):10048-53. PubMed ID: 8626560
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
[TBL] [Abstract][Full Text] [Related]
8. Probing the local conformational change of alpha1-antitrypsin.
Baek JH; Im H; Kang UB; Seong KM; Lee C; Kim J; Yu MH
Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
[TBL] [Abstract][Full Text] [Related]
9. The spontaneous polymerization of plasminogen activator inhibitor type-2 and Z-antitrypsin are due to different molecular aberrations.
Wilczynska M; Lobov S; Ny T
FEBS Lett; 2003 Feb; 537(1-3):11-6. PubMed ID: 12606023
[TBL] [Abstract][Full Text] [Related]
10. Disulfide bonding arrangements in active forms of the somatomedin B domain of human vitronectin.
Kamikubo Y; De Guzman R; Kroon G; Curriden S; Neels JG; Churchill MJ; Dawson P; Ołdziej S; Jagielska A; Scheraga HA; Loskutoff DJ; Dyson HJ
Biochemistry; 2004 Jun; 43(21):6519-34. PubMed ID: 15157085
[TBL] [Abstract][Full Text] [Related]
11. Function-stabilizing mechanism of plasminogen activator inhibitor type 1 induced upon binding to alpha1-acid glycoprotein.
Smolarczyk K; Gils A; Boncela J; Declerck PJ; Cierniewski CS
Biochemistry; 2005 Sep; 44(37):12384-90. PubMed ID: 16156651
[TBL] [Abstract][Full Text] [Related]
12. Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes.
Risse BC; Chung NM; Baker MS; Jensen PJ
J Cell Physiol; 2000 Feb; 182(2):281-9. PubMed ID: 10623892
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2.
Saunders DN; Jankova L; Harrop SJ; Curmi PM; Gould AR; Ranson M; Baker MS
J Biol Chem; 2001 Nov; 276(46):43383-9. PubMed ID: 11555638
[TBL] [Abstract][Full Text] [Related]
14. Redox-active bis-cysteinyl peptides. II. Comparative study on the sequence-dependent tendency for disulfide loop formation.
Siedler F; Quarzago D; Rudolph-Böhner S; Moroder L
Biopolymers; 1994 Nov; 34(11):1563-72. PubMed ID: 7827267
[TBL] [Abstract][Full Text] [Related]
15. Human pancreas-specific protein disulfide isomerase homolog (PDIp) is redox-regulated through formation of an inter-subunit disulfide bond.
Fu X; Zhu BT
Arch Biochem Biophys; 2009 May; 485(1):1-9. PubMed ID: 19150607
[TBL] [Abstract][Full Text] [Related]
16. Enthalpy measurement using calorimetry shows a significant difference in potential energy between the active and latent conformations of PAI-1.
Sherman WA; Blouse GE; Perron MJ; Tran T; Shore JD; Gafni A
Biol Chem; 2005 Feb; 386(2):111-6. PubMed ID: 15843154
[TBL] [Abstract][Full Text] [Related]
17. Functional structure of the somatomedin B domain of vitronectin.
Zhou A
Protein Sci; 2007 Jul; 16(7):1502-8. PubMed ID: 17567740
[TBL] [Abstract][Full Text] [Related]
18. The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2.
Medcalf RL; Stasinopoulos SJ
FEBS J; 2005 Oct; 272(19):4858-67. PubMed ID: 16176260
[TBL] [Abstract][Full Text] [Related]
19. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
[TBL] [Abstract][Full Text] [Related]
20. A peptide accelerating the conversion of plasminogen activator inhibitor-1 to an inactive latent state.
Mathiasen L; Dupont DM; Christensen A; Blouse GE; Jensen JK; Gils A; Declerck PJ; Wind T; Andreasen PA
Mol Pharmacol; 2008 Sep; 74(3):641-53. PubMed ID: 18559377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
